Rare Disease MSL: GPA/MPA & Sjögren’s - Central Florida

Amgen Inc.; Orlando (FL); Vor Ort; USD 157.000 - 212.000; Vollzeit

Benefits dieser Stelle

Stock-based incentives

Retirement plan

Flexible time off

Zusammenfassung

Amgen Inc. is seeking a Medical Science Liaison for Rare Disease in Central Florida, covering GPA/MPA and Sjögren’s disease. The role is field-based, serving as a scientific resource to OLs and PHDMs and aligning with Amgen’s strategy.

Travel within Orlando/Tampa area will be expected. The MSL will advance scientific exchange, support sponsored research, and collaborate with cross-functional teams to ensure accurate, compliant dissemination of data and insights for improved patient outcomes.

Qualifikationen

• Doctorate degree or higher.
• Master’s with 3+ years in Medical Affairs.
• Bachelor’s with 5+ years in Medical Affairs.
• Sjögren’s and GPA/MPA expertise preferred.

Aufgaben

• Majority of time spent on peer-to-peer activities with Rare Disease OLs and PHDMs.
• Communicate scientific data to healthcare providers and institutions.
• Support Amgen sponsored research and investigator liaison activities.
• Provide field observations to internal stakeholders for strategy.
• Participate on project teams to support MSL strategies.
• Support congress activities and speaker training.

Kenntnisse

Medical Affairs experience

Rheumatology knowledge

Stakeholder engagement

Ausbildung

Doctorate degree

Master’s degree & 3 years Medical Affairs experience

Bachelor’s degree & 5 years Medical Affairs experience

Jobbeschreibung

Amgen Inc. is seeking a Medical Science Liaison for Rare Disease in Central Florida, covering GPA/MPA and Sjögren’s disease. The role is field-based, serving as a scientific resource to OLs and PHDMs and aligning with Amgen’s strategy.

Travel within Orlando/Tampa area will be expected. The MSL will advance scientific exchange, support sponsored research, and collaborate with cross-functional teams to ensure accurate, compliant dissemination of data and insights for improved patient outcomes.